Cart
sales@molnova.com
Ophiopogonin C
CAS No. 911819-08-4
Ophiopogonin C( —— )
Catalog No. M30953 CAS No. 911819-08-4
Ophiopogonin C' pharmacological activities may be related to the substances in nucleus mainly.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 267 | In Stock |
|
| 10MG | 395 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameOphiopogonin C
-
NoteResearch use only, not for human use.
-
Brief DescriptionOphiopogonin C' pharmacological activities may be related to the substances in nucleus mainly.
-
DescriptionOphiopogonin C' pharmacological activities may be related to the substances in nucleus mainly.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number911819-08-4
-
Formula Weight897.06
-
Molecular FormulaC46H72O17
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Boc-MLF
Antagonist of formyl peptide receptor 1 (FPR1). Reduces superoxide production induced by fMLF with an EC50 of 0.63 μM. Almost completely blocks fMLF-stimulated primary granule exocytosis.
-
[D-Cys6,Asn7,D-Ala11...
[D-Cys6,Asn7,D-Ala11,Cys14]-Bombesin (6-14)
-
Ofatumumab
Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation.
